GIM
CC icon

Glenmede Investment Management’s Chemours CC Stock Holding History

Glenmede Investment Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$170K Buy
10,759
+468
+5% +$6.79K ﹤0.01% 1290
2025
Q2 		$118K Buy
+10,291
New +$116K ﹤0.01% 1291

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glenmede Investment Management's CC Position: Q3 2025 in Review

Glenmede Investment Management increased its Chemours (CC) stake by 4.5% in Q3 2025, buying an estimated $6.79K and bringing the position to 10,759 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

Glenmede Investment Management first reported a position in CC in Q2 2025 and has held it in 2 quarters since. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

  • Glenmede Investment Management held 10,759 shares of Chemours worth $170K as of Q3 2025.
  • Glenmede Investment Management bought 468 Chemours shares in Q3 2025, an estimated $6.79K.
  • Chemours made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1290 holding.
  • Glenmede Investment Management first reported a position in Chemours in Q2 2025 and has held it in 2 quarters since.
  • 428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.